AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate in Nigeria
3 products registered with NAFDAC — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Tavin-Em Tablets Tablet | A4-4607 | Emcure Nigeria Limited | active | 29 Jan 2030 |
| Tenofovir Disoproxil Fumarate/Efavirenz/Emtricitabine Tablet Tablet | C4-1691 | Healthline Limited | active | 6 May 2026 |
| Tenofovir Disoproxil Fumarate/Efavirenz/Emtricitabine 300 mg/600 mg/200 mg Tablet | A4-2806 | Healthline Limited | active | 6 May 2026 |
Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate — NAFDAC Registration Details
NAFDAC (Nigeria) has 3 registered products containing Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate, of which 3 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.